Nira­parib CAS 1038915-60-4

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

1038915-60-4

Name

Nira­parib

Syn­onyms

1038915-60-4 [RN] 2-{4-[(3S)-3-Piperidinyl]phenyl}-2H-indazol-7-carboxamid [Ger­man] [ACD/IUPAC Name] 2-{4-[(3S)-3-Piperidinyl]phenyl}-2H-indazole-7-carboxamide [ACD/IUPAC Name] 2-{4-[(3S)-3-Pipéridinyl]phényl}-2H-indazole-7-carboxamide [French] [ACD/IUPAC Name] 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide 2H-Inda­­zole-7-car­box­am­ide, 2-[4-[(3S)-3-piperidinyl]phenyl]- [ACD/​Index Name] Nira­parib [INN] [USAN] Nira­parib [French] [INN] Nira­parib [Span­ish] [INN] Nira­paribum [Latin] [INN] (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide 2-[4-[(3S)-3-piperidyl]phenyl]indazole-7-carboxamide 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide com­pound 56 [PMID 19873981] com­pound 56 [PMID 19873981]|MK 4827|MK-4827 MFCD17779309 [MDL num­ber] MK 4827 MK4827 MK-4827 MK4827 (Nira­parib) MK-4827,(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide Nira­parib ; MK 4827 ; MK4827 UNII :HMC2H89N35 UNII-HMC2H89N35

Mol­e­c­u­lar Structure

SMILES

c1cc2cn(nc2c(c1)C(=O)N)c3ccc(cc3)[C@@H]4CCCNC4

Std­InChI

InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1

Std­InChIKey

PCHKPVIQAH­N­QLW-CQSZACIVSA-N

Mol­e­c­u­lar Formula

C19H20N4O

Mol­e­c­u­lar Weight

320.388

MDL Number

MFCD17779309

Prop­er­ties

Appear­ance

White pow­der or yel­low pow­der

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Nira­parib CAS 1038915-60-4 

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC,HNMR

Puri­ty

98.0%～102.0%

Opti­cal purity

99%min

Heavy Met­als

≤20ppm

Loss on Drying

≤2.0%

Residue on Ignition

≤0.1%

Total Impu­ri­ties

2.0%max

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

It is a new API, com­mon­ly used as anti-tumor drugs.

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​n​i​r​a​p​a​r​i​b​-​c​a​s​-​1​0​3​8​9​1​5​-​6​0​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).